Preprint
Article

This version is not peer-reviewed.

Association Between Muscle Mass Percentage and Blood Pressure in Children and Adolescents: A Cross-Sectional Study

Submitted:

28 October 2026

Posted:

29 October 2026

You are already at the latest version

Abstract
Background. Excess adiposity is a well-established risk factor for elevated blood pressure in children. However, increasing evidence suggests that alterations in body composition, including reduced muscle mass and increased visceral fat, may also play an important role in the development of primary hypertension. Low muscle mass has been linked to arterial stiffness and increased cardiometabolic risk. Material and methods. A cross-sectional study was conducted in 1,002 children, of whom 715 had complete body composition data for primary analysis. Anthropometric measurements, body composition assessed by bioelectrical impedance analysis (BIA), and blood pressure measured using the oscillometric method were obtained. BP was assessed during one visit. Participants were categorized according to blood pressure status. Results. No significant differences were observed in body fat percentage between groups with different blood pressure levels (p = 0.363). In contrast, lower muscle mass percentage was significantly associated with higher blood pressure (p = 0.004). Similarly, lower total body water was associated with increased risk of hypertension (p = 0.004). Conclusions. Lower relative muscle mass, rather than increased body fat, was associated with elevated blood pressure. These findings highlight the potential role of muscle mass as a modifiable factor in the prevention of pediatric hypertension.
Keywords: 
;  ;  ;  

1. Introduction

Elevated blood pressure in childhood is an increasingly important public health concern, as it tracks into adulthood and contributes to the early development of cardiovascular disease [1]. Excess body fat is considered one of the main determinants of increased blood pressure in children and accounts for a substantial proportion of the risk of developing hypertension [2]. Although not all overweight or obese individuals develop hypertension, weight gain is generally associated with a corresponding increase in blood pressure [3]. Similar relationships have been consistently demonstrated in pediatric populations [4].
Over recent decades, the prevalence of overweight and obesity among children and adolescents has increased markedly worldwide [5]. Childhood obesity is strongly associated with an increased risk of early cardiovascular complications, including elevated systolic and diastolic blood pressure, dyslipidemia, and insulin resistance [6].
However, the assessment of cardiovascular risk based solely on body mass index (BMI) remains challenging in pediatric populations. Due to dynamic changes in body composition during growth, sexual maturation, and puberty, BMI does not accurately reflect true adiposity [7,8]. Increases in BMI can result not only from excess fat accumulation but also from gains in fat-free mass (FFM), particularly during growth spurts [9]. Therefore, direct measures of body composition provide more precise insights into the distinct contributions of fat and lean tissues to cardiometabolic risk [10].
Recent evidence underscores that children with primary hypertension often present with altered body composition profiles characterized not only by excess visceral adiposity but also by a relative deficit in skeletal muscle mass or functional muscle strength [11]. Skeletal muscle tissue plays a critical role in metabolic regulation, insulin sensitivity, and vascular hemodynamics. Low muscle mass and reduced muscular strength (e.g., lower relative handgrip strength) have been linked to arterial stiffness, impaired microvascular function, and elevated blood pressure in youth, independently of overall adiposity [12,13]. Furthermore, longitudinal studies indicate that while cumulative adiposity drives metabolic risk, optimal muscle mass and physical fitness may exert a protective effect against early vascular remodeling [14].
While the contribution of adiposity to pediatric hypertension is well established, the specific role of skeletal muscle mass and muscular quality remains less fully elucidated. Most historical studies have focused primarily on BMI or total body fat, potentially masking the independent and protective role of muscle mass in pediatric blood pressure regulation [15]. Previous pediatric studies have primarily focused on adiposity and BMI, whereas the association between relative muscle mass and blood pressure across childhood and adolescence remains insufficiently characterized.

Aim of the Study

The aim of this study was to assess the association between skeletal muscle mass and blood pressure in children and adolescents. We hypothesized that lower muscle mass is associated with higher systolic and diastolic blood pressure.

2. Materials and Methods

2.1. Study Population

The study initially enrolled 1,250 children randomly selected from primary schools and kindergartens. The inclusion criteria were: written informed consent provided by a parent or legal guardian along with assent from the child, age between 4 and 15 years, regular attendance at a participating school or kindergarten, and a health status allowing full participation in all study procedures. Children with a prior diagnosis of primary or secondary arterial hypertension were not eligible.
The exclusion criteria comprised: lack of parental/legal guardian consent (n = 110), lack of child assent (n = 90), contraindications to bioelectrical impedance analysis (e.g., diagnosed epilepsy or active menstruation at the time of examination) (n = 30), age outside the defined range, and a prior diagnosis of hypertension or current use of antihypertensive medication (n = 18).
After applying these criteria, a final total of 1,002 children were included in the statistical analysis. Out of a total group of 1,002 children, 287 participants declined body composition assessment or had incomplete muscle mass records. Ultimately, 715 participants were included in the final analysis.

2.2. Anthropometric and Body Composition Measurements

Body height and weight were measured using standardized anthropometric procedures. Body composition was assessed using multi-frequency bioelectrical impedance analysis (BIA) with a Tanita BC-420 MA analyzer for children aged ≤6 years and a Tanita BC-418 MA analyzer for children aged >6 years. Both devices comply with European medical device directives (MDD 93/42/EEC) [16]. All measurements were conducted under strictly standardized morning conditions, following standard pre-test preparation guidelines (fasting state, empty bladder).

2.3. Blood Pressure Measurement

Arterial blood pressure was measured using a validated automated oscillometric device (Welch Allyn Spot Vital Signs 4200B-E2) with an appropriately sized cuff placed on the right arm [17]. For each participant, three consecutive measurements were recorded at 2-minute intervals after a 10-minute quiet resting period in a seated position. The mean of these three readings was calculated and used for subsequent analyses. All procedures adhered to established pediatric blood pressure measurement guidelines.
Blood pressure status was categorized using age-, sex-, and height-specific percentile charts derived from the Polish nationwide OLA and OLAF studies [18], as well as the 2016 European Society of Hypertension (ESH) guidelines for the management of high blood pressure in children and adolescents [19]. BP classification was based on measurements obtained during a single study visit and therefore did not constitute a diagnosis of persistent hypertension.

2.4. Statistical Analysis

Continuous variables were evaluated for distributional normality using the Shapiro–Wilk test and visual inspection of Q–Q plots. Quantitative parameters are presented as mean ( x ¯ ) and standard deviation (SD), as well as median (M) to account for skewed sub-distributions. Differences in body composition indicators across blood pressure classifications (normal blood pressure, high-normal blood pressure, and hypertension) and age/sex strata were assessed using one-way analysis of variance (ANOVA) or the non-parametric Kruskal–Wallis test where distributional assumptions were violated, followed by appropriate post-hoc pairwise comparisons. Independent sample Student’s t-tests or Mann–Whitney U tests were employed for two-group sex comparisons across age categories. To examine the independent and interactive contributions of demographic and hemodynamic factors on body composition parameters (muscle mass %, total body water %, and body fat %), three-way ANOVA models were constructed with sex, age group, and blood pressure classification entered as fixed factors. Statistical significance was established at a two-tailed α = 0.05 (* p < 0.05, ** p < 0.01, *** p < 0.001). Statistical analyses were performed using Statistica software (StatSoft / TIBCO Software Inc.) and IBM SPSS Statistics.

2.5. Ethical Considerations

The study protocol was approved by the Bioethics Commission of the University of Rzeszów (Decision No. 19/12/2015, dated 2 December 2015). All procedures were conducted in strict accordance with the ethical standards of the institutional research committee and the 1964 Declaration of Helsinki and its later amendments.

3. Results

No statistically significant differences in the percentage of body fat were found between groups of people with different levels of blood pressure. Lower percentages of muscle mass and total body water were significantly associated with an increased prevalence of elevated blood pressure (p = 0.004; Table 1).
Body mass components, as a normal part of physiology, change with age. Muscle mass and total body water content is higher in boys compared to girls and, with the exception of the youngest children, the difference is highly statistically significant. Only in the oldest girls the amount of body fat is significantly higher compared to the group of boys (p < 0.001) (Table 2).

Association Between Body Composition and Blood Pressure

When stratified by sex, a statistically significant association between muscle mass percentage and blood pressure classification was observed among boys (p = 0.006), but not among girls (p = 0.283). Normotensive boys exhibited the highest relative muscle mass (mean: 78.5 ± 7.2%, median: 79.0%), whereas boys categorized with high-normal blood pressure and hypertension presented with significantly reduced muscle mass percentages (75.7 ± 8.3% and 76.4 ± 6.5%, respectively). In girls, muscle mass percentages remained comparable across blood pressure strata (76.0%, 76.0%, and 74.7%, respectively)(Table 3).
Stratification by age revealed that the inverse relationship between muscle mass percentage and blood pressure status became progressively more prominent with advancing age. In the youngest cohort (4–6 years), no significant differences were observed across blood pressure categories (p = 0.458). Conversely, in children aged 7–11 years, lower muscle mass percentage was significantly associated with elevated blood pressure (p = 0.017; normal blood pressure: 79.0 ± 6.9% vs. hypertension: 76.7 ± 6.0%). This divergence was even more marked among adolescents aged 12–15 years (p = 0.003), where hypertensive individuals exhibited a substantial reduction in muscle mass percentage compared to their normotensive peers (mean: 73.2 ± 8.9% vs. 78.6 ± 9.4%; median: 74.7% vs. 80.8%) (Table 4).
When stratified simultaneously by sex and age group, significant associations between muscle mass percentage and blood pressure categories were observed in specific developmental windows. In girls, muscle mass percentage differed significantly across blood pressure groups only in the 7–11-year age cohort (p = 0.037), showing an inverse gradient from normotension (78.9 ± 6.9%) to hypertension (75.5 ± 6.5%). In boys, a significant difference emerged in the 12–15-year group (p = 0.045), with normotensive adolescents exhibiting higher muscle mass (82.5 ± 6.8%) compared to peers with high-normal blood pressure (76.8 ± 11.8%) or hypertension (79.6 ± 7.5%). Other age strata did not reach statistical significance (p > 0.05) (Table 5).
abbreviations: * p < 0.05, ** p < 0.01, *** p < 0.001. N, sample size; x ¯ , arithmetic mean; M, median; SD, standard deviation; p, statistical significance.
These findings were further evaluated using a three-way analysis of variance (ANOVA). Blood pressure classification showed a statistically significant main effect on muscle mass percentage (p = 0.019) and total body water percentage (p = 0.008), but not on body fat percentage (p = 0.700). Significant main effects and interactions were identified for sex and age group across all three parameters (p < 0.001). However, neither the two-way interactions involving blood pressure classification (sex × BP classification and age group × BP classification) nor the three-way interaction (sex × age group × BP classification) reached statistical significance (p > 0.05 for all) (Table 6).

4. Discussion

Excess adiposity has traditionally been recognized as a primary risk factor for pediatric hypertension. However, emerging evidence indicates that cardiovascular risk is not driven solely by total fat mass. Phenotypes such as metabolically healthy obesity (MHO) and metabolically obese normal-weight (MONW) demonstrate that metabolic and vascular dysfunction can dissociate from overt body mass indices [20,21,22,23]. Recent observations indicate that pediatric primary hypertension may be characterized by an unfavorable muscle to fat balance specifically, a relative decrement in lean mass alongside altered hydration status rather than an absolute excess of adipose tissue alone [10].
Our findings support this paradigm. Across our study cohort, children with elevated blood pressure presented with significantly lower muscle mass percentage and total body water percentage compared to their normotensive peers, whereas differences in body fat percentage did not reach statistical significance. In sex- and age-stratified analyses, statistically significant associations were observed in selected age- and sex-specific groups, although formal interaction analyses did not demonstrate significant modification of the association by sex or age (Table 3, Table 4, Table 5 and Table 6). These results are consistent with previous reports by Han et al., who noted an inverse relationship between muscle mass and blood pressure in broader cohorts [24], as well as pediatric data demonstrating independent correlations between bioelectrical impedance indices and hemodynamic profiles [25].
The inverse association between relative muscle mass and blood pressure may be explained by several interrelated metabolic and vascular mechanisms. Skeletal muscle contributes substantially to glucose disposal and metabolic homeostasis and acts as an endocrine organ through the release of myokines, which may influence vascular function and insulin sensitivity [26,27,28,29,30,31]. Lower relative muscle mass may therefore be associated with an unfavorable cardiometabolic profile and impaired vascular regulation. However, these mechanisms were not directly assessed in the present study and should therefore be considered as possible explanations rather than demonstrated pathways. Adequate skeletal muscle mass also represents a primary sink for glucose clearance, buffering against insulin resistance and subsequent sympathetic nervous system activation, both of which are central drivers of arterial stiffness and elevated systemic resistance in youth [26,31].
The lower total body water percentage observed in children with elevated blood pressure may partly reflect differences in relative lean tissue, given the close relationship between muscle mass and body water. However, hydration status can also influence BIA-derived estimates of body composition, and the cross-sectional design of the present study does not allow determination of the direction or mechanisms of this association [32].
Maintaining total body fat in a favourable range and an appropriate accretion of muscle mass is essential to mitigate cardiovascular risk and attenuate elevated blood pressure [33,34]. This phenotype-oriented approach aligns with emerging clinical modalities that move beyond traditional BMI screening, utilizing digital phenotyping and decentralized technologies for precise cardiometabolic stratification [35]. Furthermore, recognizing the protective role of muscle mass is increasingly vital in contemporary clinical practice; pharmacotherapies that induce substantial weight loss, such as glucagon-like peptide-1 receptor agonists (GLP-1 RAs), frequently result in concurrent lean mass reduction, which may inadvertently compromise vascular buffering capacity if not counterbalanced by muscular preservation strategies [36]. Undoubtedly, such observations highlight that pediatric hypertension prevention must integrate both regular body composition monitoring and dedicated neuromuscular interventions.

5. Strengths and Limitations

Several limitations of the current study should be acknowledged. First, the cross-sectional design precludes any definitive causal inferences regarding whether diminished muscle mass precedes elevated blood pressure or reflects secondary physical inactivity. Second, body composition was assessed via bioelectrical impedance analysis (BIA); although validated and practical for large pediatric populations, BIA estimates can be influenced by acute hydration state and ambient testing conditions. Third, our study did not assess biological maturation via Tanner staging, which represents a critical determinant of muscle mass expansion and hormonal shifts, particularly in the 12-15 year age cohort. Fourth, blood pressure status was classified based on three consecutive measurements obtained during a single visit; therefore, participants in the elevated blood pressure or hypertension categories were not formally diagnosed with sustained chronic arterial hypertension, which in clinical practice requires confirmation across multiple separate visits or via 24-hour ambulatory blood pressure monitoring (ABPM). Finally, neither dietary patterns nor daily physical activity volumes were directly recorded; future pediatric cohorts would benefit from incorporating standardized dietary assessments aligned with contemporary cardiovascular guidelines [37] alongside device-based motion monitoring such as calibrated accelerometry to delineate the distinct interactions between movement behaviors, diet quality, and lean mass accretion [38].

6. Conclusions

In summary, lower percentages of muscle mass and total body water were significantly associated with elevated blood pressure in children and adolescents, whereas total body fat percentage showed no independent divergence. Promoting regular physical activity to stimulate muscular development alongside weight management may serve as an effective strategy in pediatric hypertension prevention. Longitudinal studies incorporating pubertal staging are warranted to validate these relationships over time.

References

  1. Flynn JT, Kaelber DC, Baker-Smith CM, Blowey D, Carroll AE, Daniels SR, et al. Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents. Pediatrics. 2017;140(3):e20171904. [CrossRef]
  2. Kaelber DC, Liu W, Ross M, Localio AR, Leon JB, Pace WD, et al. Trends in pediatric hypertension and body mass index. Pediatr Nephrol. 2020;35(4):653–660. [CrossRef]
  3. World Health Organization. Obesity and overweight factsheet. Geneva: WHO; 2024.
  4. Guo X, Yin X, Liu M, Liu Y. Association between body composition and blood pressure in children: A systematic review and meta-analysis. Chin J Evid Based Med. 2024;24(6):670–677.
  5. NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128.9 million children, adolescents, and adults. Lancet. 2017;390(10113):2627–2642. [CrossRef]
  6. Magliano DJ, Sacre JW, Harding JL, Gregg EW, Zimmet PZ, Shaw JE. Childhood predictors of adult cardiovascular disease. Nat Rev Endocrinol. 2022;18(8):480–492. [CrossRef]
  7. Wells JC. Body composition in childhood: Effects of growth, development, and disease. Metabolism. 2023;142:155512. [CrossRef]
  8. Cole TJ, Wells JC. Assessing pediatric body composition Beyond BMI. Am J Clin Nutr. 2022;116(3):615–626.
  9. Pietrobelli A, Agosti M. Lean body mass development during adolescence and its metabolic impact. Pediatr Res. 2023;93(4):810–818.
  10. Agbaje AO. Cumulative muscle mass and blood pressure drive arterial stiffness and carotid intima-media thickness progression in the young population. J Clin Endocrinol Metab. 2024;109(5):e1205–e1215. [CrossRef]
  11. Wójcik M, et al. Changes in Anthropometric Measurements, Body Composition, and Blood Pressure in Pediatric Populations: Role of Muscle Mass. J Clin Med. 2025;14(10):3489.
  12. Zhang Y, et al. Relative handgrip strength, muscle strength asymmetry, and risk of elevated blood pressure in children and adolescents. Front Pediatr. 2024;12:134012. [CrossRef]
  13. Ried-Larsen M, et al. Association of blood pressure, obesity and physical activity with arterial stiffness in children and adolescents. Pediatr Res. 2022;91(3):502–512.
  14. Börjeson S, et al. Muscle strength, muscularity and long-term cardiovascular risk in young populations: A prospective cohort study. Eur J Prev Cardiol. 2023;30(9):821–830.
  15. Urbina EM, et al. Pediatric Hypertension and Vascular Aging: New Insights into Body Composition and Muscle Health. Hypertension. 2023;80(7):1380–1391.
  16. Demura S, Sato S, Kitabayashi T. Percentage of Total Body Fat as Estimated by Three Automatic Bioelectrical Impedance Analyzers. J Physiol Anthropol Appl Human Sci. 2004;23(3):93–99. [CrossRef]
  17. Alpert BS. Validation of the Welch Allyn Spot Vital Signs blood pressure device according to the ANSI/AAMI SP10: 2002. Accuracy and cost-efficiency successfully combined. Blood Press Monit. 2007;12(5):345–347. [CrossRef]
  18. Kułaga Z, Litwin M, Tkaczyk M, Palczewska I, Ziółkowska H, Świąder-Leśniak A, et al. Rozkłady wartości ciśnienia krwi w populacji referencyjnej dzieci i młodzieży w wieku szkolnym [Blood pressure distributions in the reference population of school-aged children and adolescents]. Standardy Medyczne. 2010;7:853–864.
  19. Lurbe E, Agabiti-Rosei E, Cruickshank JK, Dominiczak A, Erdine S, Hirth A, et al. 2016 European Society of Hypertension guidelines for the management of high blood pressure in children and adolescents. J Hypertens. 2016;34(10):1887–1920. [CrossRef]
  20. Karelis AD, St-Pierre DH, Conus F, Rabasa-Lhoret R, Poehlman ET. Metabolic and body composition factors in subgroups of obesity: What do we know? J Clin Endocrinol Metab. 2004;89(6):2569–2575. [CrossRef]
  21. Velho S, Paccaud F, Waeber G, Vollenweider P, Marques-Vidal P. Metabolically healthy obesity: Different prevalences using different criteria. Eur J Clin Nutr. 2010;64(10):1043–1051. [CrossRef]
  22. Ding W, Cheng H, Zhao X, Hou D, Huang G, Yan Y, et al. Adipokines are Associated With Hypertension in Metabolically Healthy Obese (MHO) Children and Adolescents: A Prospective Population-Based Cohort Study. J Epidemiol. 2018;28(1):19–26. [CrossRef]
  23. Ding WQ, Cheng H, Chen F, Yan YK, Mi J. Hypertension outcomes in metabolically unhealthy normal-weight and metabolically healthy obese children and adolescents. J Hum Hypertens. 2015;29(9):548–554. [CrossRef]
  24. Han TS, Al-Gindan YY, Govan L, Hankey CR, Lean MEJ. Associations of body fat and skeletal muscle with hypertension. J Clin Hypertens. 2019;21(2):230–238. [CrossRef]
  25. Łątka M, et al. Związek pomiędzy przedziałami wodnymi i składem ciała ocenianymi metodą impedancji bioelektrycznej, a ciśnieniem tętniczym u dzieci szkolnych [Relationship between body fluids and body composition assessed by bioelectrical impedance and arterial pressure in school children]. Przegl Lek. 2016;73(1):1–6.
  26. Hittel DS, Berggren JR, Shearer J, Boyle K, Houmard JA. Myostatin decreases with aerobic exercise and associates with insulin resistance. Med Sci Sports Exerc. 2010;42(11):2023–2029. [CrossRef]
  27. Lee SJ, Reed LA, Davies MV, Girgenrath S, Goad ME, Tomkinson KN, et al. Regulation of muscle mass by follistatin and activins. Mol Endocrinol. 2010;24(10):1998–2008. [CrossRef]
  28. Boström P, Wu J, Jedrychowski MP, Korde A, Ye L, Lo JC, et al. A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature. 2012;481(7382):463–468. [CrossRef]
  29. Spiegelman BM. Banting lecture 2012: Regulation of adipogenesis: toward new therapeutics for metabolic disease. Diabetes. 2013;62(6):1774–1782. [CrossRef]
  30. Zhang W, Chang L, Zhang C, Zhang R, Li Z, Chai B, et al. Central and peripheral irisin differentially regulate blood pressure. Cardiovasc Drugs Ther. 2015;29(2):121–127. [CrossRef]
  31. Jedrychowski MP, Wrann CD, Paulo JA, Gerber KK, Szpyt J, Robinson MM, et al. Detection and quantitation of circulating human irisin by tandem mass spectrometry. Cell Metab. 2015;22(4):734–740. [CrossRef]
  32. Butcher JT, Larion S, Mintz J, Fulton DJ, Stepp DW. Skeletal muscle mass protects against vascular dysfunction and hypertension. FASEB J. 2017;31(1_Suppl):1011.7.
  33. Zou L, Wang W, Liu S. Spontaneous hypertension occurs with adipose tissue dysfunction in perilipin-1 null mice. Biochim Biophys Acta Mol Basis Dis. 2016;1862(2):182–191. [CrossRef]
  34. Li W, Wang D, Wang X, Gong Y, Cao S, Yin X. Association of Age-Related Trends in Blood Pressure and Body Composition Indices in Healthy Adults. Front Physiol. 2018;9:1574. [CrossRef]
  35. Butcher JT, Mintz JD, Larion S, Qiu S, Ruan L, Fulton DJ, et al. Increased Muscle Mass Protects Against Hypertension and Renal Injury in Obesity. J Am Heart Assoc. 2018;7(24):e009358. [CrossRef]
  36. Zhou M, et al. Beyond BMI: Smartphone Body Composition Phenotyping for Cardiometabolic Risk Assessment. arXiv. 2026;arXiv:2603.27017v2.
  37. Lichtenstein AH, et al. 2026 Dietary Guidance to Improve Cardiovascular Health: A Scientific Statement From the American Heart Association. Circulation. 2026;153(12). [CrossRef]
  38. Liang YT, Wang C, Hsiao CK. Data Analytics in Physical Activity Studies With Accelerometers: Scoping Review. J Med Internet Res. 2024;26:e59497. [CrossRef]
Table 1. Classification of blood pressure with respect to body weight composition in the whole group.
Table 1. Classification of blood pressure with respect to body weight composition in the whole group.
Body Composition Indicators
(TANITA)
Blood pressure classification p
Normal blood pressure High normal blood pressure Hypertension
N x ¯ M SD N x ¯ M SD N x ¯ M SD
FAT% 602 19.5 19.5 7.5 187 19.8 19.7 6.9 191 20.6 19.6 7.1 0.363
FFM% 602 80.5 80.5 7.5 187 80.2 80.3 6.9 191 79.4 80.4 7.1 0.363
MUSCLE MASS% 406 77.5 77.8 7.6 146 75.9 76.1 7.6 163 75.5 76.2 6.8 0.004**
TBW% 405 60.1 60.3 5.4 146 58.9 59.0 5.4 163 58.5 59.0 5.2 0.004**
Abbreviations: * p < 0.05, ** p < 0.01, *** p < 0.001; N, sample size; x̄, arithmetic mean; M, median; SD, standard deviation; p, statistical significance. Sample sizes differ across parameters due to missing impedance sub-data (FAT/FFM, n=980; MM/TBW, n=715).
Table 2. Body composition of girls and boys by age group.
Table 2. Body composition of girls and boys by age group.
Girls: x ¯ Girls: M Girls: SD Boys: x ¯ Boys: M Boys: SD p
Fat Mass (FM) [kg]
4–6 years 4.0 3.8 1.9 4.5 4.5 1.6 0.050
7–11 years 6.3 5.3 4.3 6.2 5.1 4.0 0.779
12–15 years 13.2 11.8 6.7 9.5 7.7 6.8 <0.001***
Muscle Mass (MM) [kg]
4–6 years 14.4 14.4 2.2 14.7 14.4 2.4 0.409
7–11 years 22.2 21.6 4.9 24.7 23.6 5.6 <0.001***
12–15 years 37.0 37.0 5.8 43.8 43.1 10.3 <0.001***
Total Body Water (TBW) [kg]
4–6 years 11.1 11.3 1.7 11.4 11.3 1.8 0.283
7–11 years 17.2 16.7 3.8 19.1 18.3 4.3 <0.001***
12–15 years 28.6 28.5 4.5 32.4 33.2 9.8 0.002**
Abbreviations: * p < 0.05, ** p < 0.01, *** p < 0.001; N, sample size; x̄, arithmetic mean; M, median; SD, standard deviation; p, statistical significance..
Table 3. Percentage of muscle tissue and blood pressure in boys and girls.
Table 3. Percentage of muscle tissue and blood pressure in boys and girls.
Sex MUSCLE MASS% p
Blood pressure
Normal blood pressure High normal blood pressure Hypertension
N x ¯ M SD N x ¯ M SD N x ¯ M SD
Girls 171 76.0 76.6 7.9 74 76.0 76.3 6.9 85 74.7 74.6 7.0 0.283
Boys 235 78.5 79.0 7.2 72 75.7 75.9 8.3 78 76.4 77.4 6.5 0.006**
Abbreviations: * p < 0.05, ** p < 0.01, *** p < 0.001; N, sample size; x̄, arithmetic mean; M, median; SD, standard deviation; p, statistical significance.
Table 4. Percentage of muscle tissue and blood pressure in age groups.
Table 4. Percentage of muscle tissue and blood pressure in age groups.
Age Group (years) MUSCLE MASS% p
Blood pressure
Normal blood pressure High normal blood pressure Hypertension
N x ¯ M SD N x ¯ M SD N x ¯ M SD
4-6 121 74.1 74.5 5.3 57 74.4 74.1 6.3 54 74.8 75.3 6.5 0.458
7-11 178 79.0 79.9 6.9 57 78.0 79.4 7.0 82 76.7 78.2 6.0 0.017*
12-15 107 78.6 80.8 9.4 32 74.8 77.1 9.9 27 73.2 74.7 8.9 0.003**
Abbreviations: * p < 0.05, ** p < 0.01, *** p < 0.001; N, sample size; x̄, arithmetic mean; M, median; SD, standard deviation; p, statistical significance.
Table 5. Percentage of muscle tissue and blood pressure in age groups in boys and girls.
Table 5. Percentage of muscle tissue and blood pressure in age groups in boys and girls.
Gender/Age MUSCLE MASS% p
Normal blood pressure High normal blood pressure Hypertension
N x ¯ M SD N x ¯ M SD N x ¯ M SD
Girls 4-6 48 73.9 74.3 5.4 28 76.5 75.6 5.6 31 76.6 77.5 5.9 0.143
Girls 7-11 78 78.9 79.3 6.9 31 77.3 77.9 7.5 37 75.5 74.1 6.5 0.037*
Girls 12-15 45 73.3 72.9 9.9 15 72.5 71.0 7.1 17 69.5 68.8 7.4 0.212
Boys 4-6 73 74.2 74.5 5.3 29 72.3 72.3 6.3 23 72.5 73.9 6.7 0.068
Boys 7-11 100 79.2 80.0 6.9 26 78.8 80.2 6.3 45 77.7 79.9 5.3 0.345
Boys 12-15 62 82.5 83.6 6.8 17 76.8 80.9 11.8 10 79.6 82.8 7.5 0.045*

abbreviations: * p < 0.05, ** p < 0.01, *** p < 0.001. N, sample size;  x - , arithmetic mean; M, median; SD, standard deviation; p, statistical significance.
Table 6. Impact of sex, age and blood pressure classification on the fat mass, muscle mass and total body water content.
Table 6. Impact of sex, age and blood pressure classification on the fat mass, muscle mass and total body water content.
Tested effects of factors (ANOVA) Muscle Mass [%] (p-value) TBW [%] (p-value) FAT [%] (p-value)
Main effects
Sex <0.001*** <0.001*** <0.001***
Age group <0.001*** <0.001*** 0.004**
Blood pressure (BP) classification 0.019* 0.008** 0.700
Two-way interactions
Sex × Age group <0.001*** <0.001*** <0.001***
Sex × BP classification 0.144 0.302 0.200
Age group × BP classification 0.091 0.071 0.883
Three-way interaction
Sex × Age group × BP classification 0.104 0.093 0.310
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
Copyright: This open access article is published under a Creative Commons CC BY 4.0 license, which permit the free download, distribution, and reuse, provided that the author and preprint are cited in any reuse.